Vidac Pharma Holding PLC (XETRA:T9G.DE)
| Market Cap | 23.23M-49.0% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | 0.00 |
| Shares Out | 56.95M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,600 |
| Open | 0.41 |
| Previous Close | 0.41 |
| Day's Range | 0.41 - 0.41 |
| 52-Week Range | 0.35 - 0.83 |
| Beta | n/a |
| Analysts | none |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About T9G.DE
Vidac Pharma Holding Plc, an investment holding company, engages in the discovery and development of anticancer medicines. The company is developing VDA-1102 CTCL which is in phase 2 clinical trials for the treatment of cutaneous T cell lymphoma (CTCL); and VDA-1102 Ointment, an anti-neoplastic agent that is in phase 2B clinical trials for triggering apoptosis in cancer cells with minimal effects on surrounding normal cells. It is also developing VDA-1102 IV, an anti-neoplastic agent; and VDA-1275, a potent small molecule new chemical entity that is in preclinical stage for use in the treatment of solid tumors. Vidac Pharma Holding Plc was founded in 2012 and is headquartered in London, the United Kingdom.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$T9G.DE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in T9G.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by T9G.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
T9G.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New T9G.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to T9G.DE from public contracts
Source: USAspending.gov
T9G.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from T9G.DE’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score